Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | $0 | SEC | |
| Exercise | $402.1K | SEC | |
| ExerciseD | — | SEC | |
| Buy | $154.8K | SEC | |
| AwardD | $160B | SEC | |
| Buy | $3K | SEC | |
| Buy | $11.1K | SEC | |
| Buy | $525 | SEC | |
| Buy | $16K | SEC | |
| Buy | $97 | SEC | |
| Buy | $5.4K | SEC | |
| Buy | $10.4K | SEC | |
| Buy | $2.6K | SEC | |
| Buy | $2.5K | SEC | |
| Buy | $7.6K | SEC | |
| Buy | $20.1K | SEC | |
| Buy | $17.8K | SEC | |
| Buy | $294 | SEC | |
| Buy | $117.8K | SEC | |
| Buy | $15.6K | SEC |